Hans Peter Gerber

Hans Peter Gerber

Company: 3T Bioscionces

Job title: Chief Scientific Officer


Identification of Novel pHLA Targets for Solid Tumor Targeting with ADCs 10:00 am

Discuss the advantages of intracellular targets (pHLAs) versus viral, neoantigens or conventional cell surface antigens Uncover strategies to find the most prevalent and immunogenic pHLA targets in tumors from CPI responders Review the selection of ADCs targeting pHLA targets to avoid off-tumor, on-target toxicities in normal tissuesRead more

day: Day Two

Panel Discussion: Ensuring Your ADC Is Fit For Purpose; Matching the Target Selection to the Property of Your Warhead or Your Linker Drug 2:00 pm

Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.